Key Takeaways
- • Isomorphic Labs secured £462.3 million ($2.1 billion) in a Series B round led by Thrive Capital and Google Ventures, representing the second-largest biotech funding round on record and a major vote of confidence in AI-driven drug discovery at scale.
- • UK tech investment reached £800.1 million across nine funding rounds in the week of March 31 to April 4, demonstrating sustained institutional appetite for British technology despite sector-wide funding headwinds.
- • CMR Surgical raised £154.1 million in late-stage venture funding from Trinity Capital, underscoring continued investor focus on surgical robotics and medical device innovation within the UK health tech ecosystem.
- • Zepz secured £140 million in debt financing from HSBC Innovation Banking and HSBC Private Credit, signaling institutional credit market support for established fintech platforms with proven revenue models.
- • The funding round reflects Isomorphic Labs' trajectory as a DeepMind spinout progressing from £600 million in its initial round to scaling operations globally with an enhanced AI drug design pipeline.
Summary
UK technology companies attracted £800.1 million in venture and growth-stage funding during the week ending April 4, marking a significant week-on-week increase across nine distinct funding rounds. The capital deployment was concentrated among three marquee deals, with Isomorphic Labs, CMR Surgical, and Zepz commanding the largest allocations.
Isomorphic Labs, a London-based artificial intelligence drug discovery platform and spinout from DeepMind, closed the week's dominant transaction at £462.3 million. The Series B round was jointly led by Thrive Capital and Google Ventures (Alphabet's venture arm), bringing the company's total raised to approximately $2.7 billion when including its prior $600 million Series A. The funding will support expansion of the company's AI-driven drug design engine, global business scaling, and advancement of its drug candidate pipeline toward clinical development. Market analysts characterize this as the second-largest biotech funding round to date, positioning Isomorphic Labs at the forefront of computational drug discovery alongside traditional pharmaceutical and biotech players.
CMR Surgical, a Cambridge-based developer of robotic surgical assistants, raised £154.1 million in late-stage venture funding from Trinity Capital. Founded in 2014, the company exemplifies the UK's strength in surgical robotics and medical device engineering, a subsector that continues to attract institutional capital focused on automation and precision medicine applications.
Zepz, a London-headquartered fintech platform, secured £140 million through debt financing rather than equity, with capital provided by HSBC Innovation Banking and HSBC Private Credit. This transaction signals institutional credit appetite for mature fintech businesses with established revenue streams and customer bases, reflecting a broader shift toward alternative financing structures in the sector.
The week's funding activity underscores persistent institutional investor confidence in UK-based technology companies, particularly within health tech, AI, and financial services verticals, despite broader headwinds affecting venture capital deployment across Europe and North America.
Isomorphic Labs, a London-based artificial intelligence drug discovery platform and spinout from DeepMind, closed the week's dominant transaction at £462.3 million. The Series B round was jointly led by Thrive Capital and Google Ventures (Alphabet's venture arm), bringing the company's total raised to approximately $2.7 billion when including its prior $600 million Series A. The funding will support expansion of the company's AI-driven drug design engine, global business scaling, and advancement of its drug candidate pipeline toward clinical development. Market analysts characterize this as the second-largest biotech funding round to date, positioning Isomorphic Labs at the forefront of computational drug discovery alongside traditional pharmaceutical and biotech players.
CMR Surgical, a Cambridge-based developer of robotic surgical assistants, raised £154.1 million in late-stage venture funding from Trinity Capital. Founded in 2014, the company exemplifies the UK's strength in surgical robotics and medical device engineering, a subsector that continues to attract institutional capital focused on automation and precision medicine applications.
Zepz, a London-headquartered fintech platform, secured £140 million through debt financing rather than equity, with capital provided by HSBC Innovation Banking and HSBC Private Credit. This transaction signals institutional credit appetite for mature fintech businesses with established revenue streams and customer bases, reflecting a broader shift toward alternative financing structures in the sector.
The week's funding activity underscores persistent institutional investor confidence in UK-based technology companies, particularly within health tech, AI, and financial services verticals, despite broader headwinds affecting venture capital deployment across Europe and North America.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.